Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangyang Deng

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Management and Research|December 7, 2018
The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched studyXiangyang Deng, Dongdong Lin, Lisheng Yu, et al.
CNS Neuroscience & Therapeutics|April 20, 2026
Inhibition of Microglial TRPV1 Ameliorates Brain Injury After Intracerebral Hemorrhage by Suppressing AMPK/PINK1-Mediated MitophagyKezhu Chen, Xiangyang Deng, Jun Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 2, 2023
Engineered Extracellular Vesicle-Delivered CRISPR/CasRx as a Novel RNA Editing ToolTianwen Li, Liansheng Zhang, Tao Lu, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Management and Research|December 7, 2018
The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched studyXiangyang Deng, Dongdong Lin, Lisheng Yu, et al.
CNS Neuroscience & Therapeutics|April 20, 2026
Inhibition of Microglial TRPV1 Ameliorates Brain Injury After Intracerebral Hemorrhage by Suppressing AMPK/PINK1-Mediated MitophagyKezhu Chen, Xiangyang Deng, Jun Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 2, 2023
Engineered Extracellular Vesicle-Delivered CRISPR/CasRx as a Novel RNA Editing ToolTianwen Li, Liansheng Zhang, Tao Lu, et al.
Pageof 3